FDAsafety guidance66% confidence
FDA AP — METHYLPREDNISOLONE (SUPPL)
Source: FDA
Why This Matters
Why this matters: provides agency context on safety guidance that may shape timing or evidence expectations for Sandoz; the same agency is already in play for this signal, so precedent weight is higher.
Regulatory Analysis
Application ANDA204072. Sponsor: TIANJIN TIANYAO. Submission status: AP. Submission type: SUPPL. Review priority: STANDARD. Active ingredients: METHYLPREDNISOLONE.
Supporting Context
- Therapeutic area
- Immunology · Corticosteroid
- Sub-indication
- General
Related signal: Sandoz's Methylprednisolone ANDA040194 Receives AP Status from FDA